Novel rose bengal formulation obliterates lesions in patients with deadliest of melanomas
10/02/2014
A formulation of the dye, rose bengal, which has been around for more than a century, has recently been shown to have promise in patients with cutaneous melanoma, one of the deadliest forms of the...
ERYTECH, the French biopharmaceutical company that develops innovative 'tumor starvation' treatments for acute leukemia and other oncology indications with unmet medical needs, reports positive...
Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer
10/02/2014
The New England Journal of Medicine reports positive results of a phase 1 clinical trial of the drug crizotinib against the subset of lung cancer marked by rearrangement of the gene ROS1.
Nine-valent HPV vaccine may prevent nearly 90 percent of cervical cancers
10/02/2014
Because nine human papillomavirus (HPV) subtypes were found to cause the majority of cervical precancers, a nine-valent HPV vaccine currently being investigated may be able to prevent more cervical...
Cancer therapy: Driving cancer cells to suicide
10/02/2014
Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich report that a new class of chemical compounds makes cancer cells more sensitive to chemotherapeutic drugs.
The accurate measurement of mammographic density offers the potential to improve breast cancer risk prediction and to tailor screening protocols according to risk, according to a study published in...
Potential treatments for breast, ovarian and other cancers with new discovery approach
10/02/2014
Researchers at the University of Michigan have described a new approach to discovering potential cancer treatments that requires a fraction of the time needed for more traditional methods.
Molecular pathway revealed for cancer progression of myeloid derived suppressor cells
10/02/2014
InSilico Medicine and partners provide a clear, illustrative map that allows scientists to understand MDSC conditions, and furthermore the means to infiltrate themScientists from InSilico...
Children's national researchers uncover therapeutic target linked to sepsis
10/02/2014
Yang Liu, PhD, Director and Bosworth Chair of the Cancer Biology Center for Cancer and Immunology Research at Children's National Health System, and his colleagues Pan Zheng, MD, McKnew Professor...
Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer
10/02/2014
The New England Journal of Medicine reports positive results of a phase 1 clinical trial of the drug crizotinib against the subset of lung cancer marked by rearrangement of the gene ROS1.